Home » Posts tagged with » William Sandborn
BMS’ Zeposia succeeds in True North clinical trial in ulcerative colitis
Bristol Myers Squibb (BMS) said that the phase 3 True North clinical trial evaluating Zeposia (ozanimod) in adult patients with moderate to severe ulcerative colitis (UC) met both primary endpoints. The placebo-controlled late stage trial featuring 645 patients assessed oral Zeposia as an induction and maintenance therapy for the chronic inflammatory bowel disease (IBD). ZEPOSIA […]
Business News Today
- Dam Nai wind farm Vietnam to be acquired by SN Power
- TRATON to take full ownership of US truck manufacturer Navistar for $3.7bn
- Elizabeth River Tunnels Project : Skanska to sell 50% stake for $625m
- Spanish proptech company Clikalia secures investment from Mouro Capital
- Orange Romania to acquire 54% stake in Telekom Romania Communications
- Carlyle Group invests $250m in US e-commerce company Pharmapacks
- Cano Health to merge with blank check company Jaws Acquisition in $4.4bn deal
- Naturgy to sell stake in Chilean utility CGE to China’s SGI for €2.5bn
- Arthur J. Gallagher acquires wholesale insurance broker AWIS Group
- Hub acquires insurance brokerage assets of Larry Dean Massey, Jr.
